Biotech

All Articles

Analysts go into Avidity's DMD gain, uncovering subtleties in information

.Avidity Biosciences amazed real estate investors with stage 1/2 records in Duchenne muscular dystro...

Actinogen's cortisol blocker stops working stage 2 clinical depression study

.Actinogen Medical's cortisol blocker has actually overlooked the main endpoint of a phase 2 study i...

Bivictrix chooses going exclusive only means to take ADC in to facility

.Antibody-drug conjugates (ADCs) have actually gone to the facility of several a billion-dollar biob...

TPG tops up funds to $580M for investments all over lifestyle sciences

.Possession manager TPG, which has assisted biotechs such as Sionna Rehabs and also Santa Clam Ana B...

Merck quits phase 3 TIGIT trial in lung cancer for futility

.Merck &amp Co.'s TIGIT plan has suffered an additional trouble. Months after shuttering a phase 3 m...

After a challenging year, Exscientia folds in to Recursion

.After a year specified through pipeline hairstyles, the departure of its CEO as well as layoffs, Ex...

Cullinan, after $25M bargain, return bispecific to Port

.Cullinan Rehab was impressed enough with Harbour BioMed's bispecific immune activator that it surre...

A nearer take a look at Strong Biotech's Strong 15

.In this week's incident of "The Top Line," our company are actually diving into Tough Biotech's ann...

Lilly experiences phase 2 failure of tau-targeting med

.The confetti is still soaring from Eli Lilly's celebration commemorating the approval of Alzheimer'...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable leadership hirings, shootings as...